KR910007871A - 아로일-우레아 - Google Patents

아로일-우레아 Download PDF

Info

Publication number
KR910007871A
KR910007871A KR1019900015959A KR900015959A KR910007871A KR 910007871 A KR910007871 A KR 910007871A KR 1019900015959 A KR1019900015959 A KR 1019900015959A KR 900015959 A KR900015959 A KR 900015959A KR 910007871 A KR910007871 A KR 910007871A
Authority
KR
South Korea
Prior art keywords
azabicyclo
endo
methyl
octan
compound
Prior art date
Application number
KR1019900015959A
Other languages
English (en)
Other versions
KR100196263B1 (ko
Inventor
제임스 워드 테렌스
크리스틴 화이트 자넷
브래들리 제럴드
Original Assignee
폴 에이. 리쳐
죤 와이어스 앤드 브라더 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 폴 에이. 리쳐, 죤 와이어스 앤드 브라더 리미티드 filed Critical 폴 에이. 리쳐
Publication of KR910007871A publication Critical patent/KR910007871A/ko
Application granted granted Critical
Publication of KR100196263B1 publication Critical patent/KR100196263B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Glass Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Removal Of Specific Substances (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

아로일-우레아
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. (엔도)-N-〔〔(8-메틸-8-아자비사이클로〔3.2.1〕옥탄-3-일〕아미노〕카보닐〕-2-(사이클로프로필메톡시)벤젠 아미드 또는 이의 약제학적으로 허용되는 산부가염.
  2. (a) 2-사이클로프로필메톡시벤조일이소시아네이트를 (엔도)-8-메틸-8-아자비사이클로〔3.2.1〕옥탄-3-아민과 반응시키거나. (b) 2-사이클로프로필메톡시벤조일우레아를(엔도)-8-메틸-8-아자비사이클로〔3.2.1〕옥탄-3-아민과 반응시키거나, (c) 2-(사이클로프로필메톡시)벤즈아미드를(엔도)-8-메틸-8-아자비사이클로〔3.2.1〕옥탄-3-이소시아네이트와 반응시키거나. (d) 1-〔(엔도)-8-메틸-8-아자비사이클로〔3.2.1〕옥탄-3-일〕우레아를 2-(사이클로프로필메톡시)벤조산 또는 이의 아실화 유도체로 아실화시키거나, (e) (엔도)-N-〔〔(8-메틸-8-아자비사이클로〔3.2.1〕옥탄-3-일〕아미노〕카보닐〕-2-하이드록시벤즈아미드를 사이클로프로필메틸화 시키거나, (f) 사이클로프로필메탄올을 일반식(Ⅷ)의 화합물과 반응시키거나, (g) 구조식(Ⅸ)의 화합2물을 메틸화시키거나, (h) 유리염기, (엔도)-N-〔〔(8-메틸-8-아자비사이클로〔3.2.1〕옥탄-3-일〕아미노〕카보닐〕-2-(사이클로프로필메톡시)벤즈 아미드를 이의 약제학적으로 허용되는 산부가염으로 전환시키거나 산부가염을 유리 염기로 전환시킴을 특징으로 하여, 제1항에 따른 화합물을제조하는 방법.
    상기식에서 X는 이탈그룹이다.
  3. 제1항에서 청구한 화합물을 약제학적으로 허용되는 담체와 결합된 형태로 포함하는 약제학적 조성물.
  4. 제3항에 있어서 사이클로-옥시게나제 억제제를 추가로 함유하는 약제학적 조성물.
  5. 제1항에 따른 화합물 및 암 치료에 있어서 동시, 별도 또는 연속 투여용 배합제제로서 암화학 요법제를 함유하는 약제.
  6. 약제로서의 용도를 위한 제1항에 청구된 화합물.
  7. 불안 해소제로서의 용도를 위한 제1항에 청구된 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900015959A 1989-10-07 1990-10-06 아로일 우레아 유도체 KR100196263B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB89226229 1989-10-07
GB898922622A GB8922622D0 (en) 1989-10-07 1989-10-07 Aroylureas

Publications (2)

Publication Number Publication Date
KR910007871A true KR910007871A (ko) 1991-05-30
KR100196263B1 KR100196263B1 (ko) 1999-06-15

Family

ID=10664224

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900015959A KR100196263B1 (ko) 1989-10-07 1990-10-06 아로일 우레아 유도체

Country Status (22)

Country Link
EP (1) EP0422846B1 (ko)
JP (1) JP2960141B2 (ko)
KR (1) KR100196263B1 (ko)
CN (1) CN1042534C (ko)
AT (1) ATE101607T1 (ko)
AU (1) AU634584B2 (ko)
CA (1) CA2027041C (ko)
CZ (1) CZ280228B6 (ko)
DE (1) DE69006675T2 (ko)
DK (1) DK0422846T3 (ko)
ES (1) ES2062398T3 (ko)
FI (1) FI96419C (ko)
GB (2) GB8922622D0 (ko)
HU (1) HU204821B (ko)
IE (1) IE64043B1 (ko)
IL (1) IL95892A (ko)
MX (1) MX22719A (ko)
NZ (1) NZ235583A (ko)
PT (1) PT95490B (ko)
RU (2) RU1817778C (ko)
SK (1) SK480890A3 (ko)
ZA (1) ZA907993B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8922622D0 (en) * 1989-10-07 1989-11-22 Wyeth John & Brother Ltd Aroylureas
GB9106571D0 (en) * 1991-03-27 1991-05-15 Erba Carlo Spa Derivatives of substituted imidazol-2-one and process for their preparation
GB2269747B (en) * 1992-08-19 1996-06-05 Wyeth John & Brother Ltd Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists
GB9217629D0 (en) * 1992-08-19 1992-09-30 Wyeth John & Brother Ltd Aroylureas
GB9314174D0 (en) * 1993-07-08 1993-08-18 American Home Prod 5-ht3-antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62231B1 (en) * 1987-12-24 1995-01-11 Wyeth John & Brother Ltd Heterocyclic compounds
DK443489D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
GB8922622D0 (en) * 1989-10-07 1989-11-22 Wyeth John & Brother Ltd Aroylureas

Also Published As

Publication number Publication date
HU204821B (en) 1992-02-28
CA2027041C (en) 2000-08-08
GB9021695D0 (en) 1990-11-21
SK279469B6 (sk) 1998-11-04
FI96419B (fi) 1996-03-15
RU2036923C1 (ru) 1995-06-09
ATE101607T1 (de) 1994-03-15
EP0422846A3 (en) 1991-12-04
AU634584B2 (en) 1993-02-25
IE64043B1 (en) 1995-06-28
PT95490A (pt) 1991-07-05
HUT55391A (en) 1991-05-28
ZA907993B (en) 1992-06-24
DE69006675T2 (de) 1994-05-26
CZ280228B6 (cs) 1995-12-13
IE903583A1 (en) 1991-04-10
DE69006675D1 (de) 1994-03-24
JPH03133986A (ja) 1991-06-07
IL95892A0 (en) 1991-07-18
GB2236528A (en) 1991-04-10
EP0422846B1 (en) 1994-02-16
GB2236528B (en) 1993-06-30
CA2027041A1 (en) 1991-04-08
SK480890A3 (en) 1998-11-04
CN1042534C (zh) 1999-03-17
AU6374990A (en) 1991-04-11
HU906355D0 (en) 1991-04-29
ES2062398T3 (es) 1994-12-16
DK0422846T3 (da) 1994-03-14
RU1817778C (ru) 1993-05-23
IL95892A (en) 1994-06-24
GB8922622D0 (en) 1989-11-22
KR100196263B1 (ko) 1999-06-15
FI96419C (fi) 1996-06-25
NZ235583A (en) 1991-12-23
JP2960141B2 (ja) 1999-10-06
MX22719A (es) 1993-09-01
CN1050875A (zh) 1991-04-24
CZ480890A3 (en) 1995-07-12
FI904912A0 (fi) 1990-10-05
PT95490B (pt) 1997-11-28
EP0422846A2 (en) 1991-04-17

Similar Documents

Publication Publication Date Title
UY25225A1 (es) Derivados de pleuromutilina utiles como agentes antimicrobianos
KR880009020A (ko) 신규 치료법
TW255881B (ko)
ATE104971T1 (de) 2-aminopyrimidinon-derivate.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
DE69025104D1 (de) Thiazolderivate, Verfahren zur Ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
ES2035824T3 (es) Procedimiento para preparar compuestos profarmacos y preparaciones que los contienen.
HU906284D0 (en) Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
KR910007871A (ko) 아로일-우레아
KR900014406A (ko) 세펨 화합물 및 이의 제조방법
KR880013886A (ko) 신규 알칸술폰아닐리드 유도체, 그의 제조방법 및 이를 함유하는 제약 조성물
ATE71944T1 (de) Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
KR910007881A (ko) 아미노피리디닐아미노페놀 및 관련화합물, 이들의 제조방법 및 중간체 및 약제로서의 이들의 용도
KR910002775A (ko) 방향족 카복실산 아미드
KR880000432A (ko) 4(3H)-옥소-5,6,7,8-테트라히드로피리도-2,3-d 피리미딘 유도체
KR920004402A (ko) 신규 퀴놀린 카르복실산 유도체, 상기 화합물 함유 항균제 및 상기 화합물 제조 방법
ATE27813T1 (de) N-substituierte 1-(4&#39;-alkylsulfonylphenyl)-2amino-1,3-propanediol-derivate.
DE3786256D1 (de) Antifolat-mittel.
NO176018C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive S-enantiomerer av substituerte 2-aminotetraliner
ES2162794T3 (es) Compuestos farmaceuticos que contienen ametocaina.
KR930023338A (ko) 데포우 제제
SE8802066D0 (sv) N-imidazolyl derivatives of bicyclic compounds useful in medicine
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
SE8004129L (sv) Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
AU581856B2 (en) 1-(4&#39;-alkylthiophenyl)-2-amino-1, 3-propanediol N-substituted derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee